LCDRD

Levy CIMAR's Laboratory for Combinatorial Drug Regimen Design (LCDRD)

Advanced Facilities for Cutting-Edge Research Offering Fee-for-Service Contracts.

Learn More
Featured Trainees

Levy CIMAR's Featured Trainees

Here we highlight trainees (students and professionals) who stand out for their efforts in the fight against antimicrobial resistance.

Learn More
Education

Reaching Out to Brockton High

33 Sophomores and Seniors presented their original experiments and data on AMR to a wide audience at Tufts University and Tufts Medical Center.

Learn More
CIMAR

Levy CIMAR

Innovating to Protect Humanity from the Global Threat of Antimicrobial Resistance: Integrating Solutions Across Human and Veterinary Medicine, Stewardship, and Awareness.

Join Us
Research

Multidrug Therapies

Using Combination Chemotherapies to Cure Otherwise Untreatable Infections.

Explore Research

Our Mission

Innovating to Protect Humanity from the Global Threat of Antimicrobial Resistance: Integrating Solutions Across Human and Veterinary Medicine, Stewardship, and Awareness

—  Latest Updates

News

Tufts Researchers Find Link Between Dog-Human Antibiotic Resistance

For many people, pets are family; just as close to them as the humans in their life. However, a new study suggests that closeness can create a concerning health issue making prescribed medicines less effective. …

IDSA announces Tufts Medical Center Among Recipients of Antimicrobial Stewardship Centers of Excellence Designation

The Infectious Diseases Society of America (IDSA) announced today the recipients of its Antimicrobial Stewardship Centers of Excellence (CoE) designation. …

CIMAR Featured in Spotlight on Research and Collaboration

Given an increasingly difficult funding climate, finding the research strengths of the university and focusing resources on those areas is a priority for Tufts. After a year-and-a-half consultative process involving researchers from across the university, five thematic priority areas emerged. …

Events

Robin Patel, MD, the Mayo Clinic and the Antibacterial Resistance Leadership Group (ARLG)

April 30, 2027

Sep 03, 2026

On behalf of the Tufts University School of Medicine’s Department of Molecular Biology & Microbiology and Tufts Medical Center’s Division of Geographic Medicine and Infectious Diseases, we are pleased to announce that the Mayo Clinic’s Robin Patel, MD, will be our next speaker for the annual Louis Weinstein Lecture to be held on Friday, April 30th, and 12 noon.

Diagnostic Stewardship as a Tool for Antimicrobial Stewardship – Tufts Medical Center’s Shira Doron, MD

October 26, 2023

Levy CIMAR’s own Shira Doron, MD, presented for this month’s Science Seminar on the topic of “Diagnostic Stewardship as a Tool for Antimicrobial Stewardship.” Dr. Doron is a widely recognized expert in the fields of antimicrobial and diagnostic stewardship, and among her many titles, is Chief Infection Control Officer for Tufts Medicine. There, she Infection Control and Antimicrobial Stewardship.

Discovery and Development of Novel Antimalarials and Their Use as Chemical Tools to Discover New Biology of the Malaria Parasite – WEHI’s Professor Alan F. Cowman

September 28, 2023

The Levy CIMAR kicked off its 2023-2024 seminar season today with a talk from world-renowned Professor Alan F. Cowman, who among his many roles is acting Director of Australia’s Walter and Eliza Hall Institute of Medical Research (WEHI). An internationally acclaimed expert in malaria research, Prof. Cowman heads a laboratory at WEHI where he and his team aim to advance the understanding of how malaria-causing parasites invade human cells.

Our Trainees

Rebekah Johnson

Rebekah Johnson

Rebekah Johnson, High School Citizen Scientist and Antimicrobial Steward at the Little Rock Zoo

Ashley Luo

Ashley Luo

Ashley Luo, Second-Year Molecular Microbiology (MERGE-ID Track) PhD Candidate

Maryam Utegulova

Maryam Utegulova

Maryam Utegulova, 2025 Recipient of the Levy CIMAR Undergraduate Summer Internship in Science and Medicine

Publications

Direct bacterial transcript visualization illuminates spatiotemporal environmental adaptation of Mycobacterium tuberculosis in the lung

Anna-Lisa E Lawrence, Shumin Tan

Sci Adv. 2026 Aug 14;12(33):eaeb8377. Epub 2026 Aug 12.

Indication-based clinical decision support for inpatient urine testing: impacts on utilization, appropriateness, and antibiotic prescribing

Mario Luis Valdez Imbert, Allyson Larcena Tipgos, Majd Alsoubani, Maureen Campion, Rachel Erdil, Shira Doron, Gabriela Andujar Vazquez, Kap Sum Foong

Antimicrob Steward Healthc Epidemiol. 2026 Jul 24;6(1):e229. eCollection 2026.

EXPRESS: Factors associated with antimicrobial drug prescription in cats receiving outpatient care at a veterinary teaching hospital

Ian M DeStefano, Claire L Fellman, Paula M Snippes Vagnone, Melissa A Cumming, Jennifer L Dale, Abbey Ruhland, Jaclyn Dietrich, Catherine M Brown, Esther Fortes, Nicolas N Epie, Amanda Beaudoin, Katherine Janiszewski, Jessica Leaf, Shira Doron, Matthew Doucette, Stephen D Cole

Clin Infect Dis. 2026 Jul 8;82(6):e1138-e1144.

Loss of essential outer membrane functions causes drug hypersensitization in Acinetobacter baumannii overexpressing multidrug efflux pumps

Efrat Hamami, Wenwen Huo, Katherine Neal, Isabelle Neisewander, ­Shivangi, Joel S. Freundlich, Edward Geisinger, Ralph R. Isberg

mBio. 2026 Jun 24:e0090226.

Growth arrest of Mycobacterium tuberculosis in acidic environments enhances their survival of antibiotic treatment

Eun Seon Chung, William C. Johnson , Maliwan Kamkaew, Timothy A. Fitzgerald, Morgan E. McNellis, Trever C. Smith II, Srinivasan Vijay, Nguyen Thuy Thuong Thuong, Shumin Tan, Bree B. Aldridge

PLoS Biol. 2026 Jun 22;24(6):e3003857.

Find us on BlueSky

You can also find us on

Our Values

The Levy CIMAR is committed to a culture of diversity, equity, and inclusion both within our organization and for all people who are impacted by our work. We strive for health equity for people from all backgrounds and identities, and we actively support societal and institutional structures that promote justice and equality. We are also committed to being a safe, respectful, and inclusive environment for our trainees, staff, faculty, affiliates, and partners. One Health acknowledges the interconnectedness of allhumans, along with animals and our environments. Antimicrobial resistance impacts us all.